Second Sight Medical Products

+$0.05 (+2.59%) Today
-$0.06 (-2.99%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EYES and other ETFs, options, and stocks.

About EYES

Second Sight Medical Products, Inc. engages in the development, manufacture, and marketing of implantable visual prosthetics. It offers Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device intended to provide artificial vision to individuals who are blind due to a wide range of causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury.

CEO
Scott Dunbar
Employees
15
Headquarters
Sylmar, California
Founded
1998

EYES Key Statistics

Market cap
85.72M
Price-Earnings ratio
—
Dividend yield
—
Average volume
506.73K
High today
$2.18
Low today
$2.02
Open price
$2.02
Volume
346.64K
52 Week high
$7.64
52 Week low
$1.14

EYES Earnings

-$0.12
-$0.08
-$0.04
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.06 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure